Grupo Cibest S.A. (CIB): Financial results for Q2 2026

Banco Agromercantil (Banco BAM) in Guatemala received US$70 million in subordinated financing from Colombia’s Grupo Cibest, according to the holding company. The funds, structured as Tier 2 capital, are intended to strengthen Banco BAM’s solvency and expand lending, particularly to SMEs and independent workers.

Commercial International Bank (CIB) reported 1H26 consolidated revenue of EGP 65.6bn and net profit of EGP 39.3bn. 2Q26 net profit was EGP 21.5bn. The bank reported gross loans of EGP 680bn, deposits of EGP 1.30tn, NPLs-to-gross loans of 1.49%, and Tier capital of EGP 257bn (28.4% of RWA).

Colombia’s MSCI COLCAP rose 2.37% to 2,132.79 on Monday (May 25), its biggest gain in weeks, after the index was at cycle-low oversold levels and oil prices eased. The report says Brent fell below $100 following Iran-related “framework” relief, lifting regional risk sentiment. With Colombia’s May 31 presidential first round six days away and a poll blackout active, BanRep was unchanged at 11.25%.

Micron Technology (MU) is at the center of a debate between Michael Burry and Jim Cramer. Burry has taken a bearish stance with put options expiring in June 2027, betting on a significant stock decline. Cramer, however, is bullish, citing Micron's strong earnings, strategic customer agreements, and planned buybacks. Micron reported Q4 revenue of $54.23B, beating estimates, and guided Q1 revenue at $61.5B. The stock trades at about 7x forward earnings with an analyst target of $1,533.80.

William Blair maintained a Market Perform rating on Tesla (TSLA) after Q3 deliveries of 486,532 vehicles exceeded expectations. Energy storage deployments missed estimates due to supply constraints. Tesla's Megapack entered Nvidia's DSX Ready program. Shares trade at a premium valuation, with a P/E ratio of 345. Risks include competition and geopolitical exposure. Oppenheimer reiterated a Perform rating, while StoneX kept a Buy rating with a $475 price target.

BNP Paribas Exane reduced its Nike (NKE) price target to $19 from $23, citing weak guidance and a multi-year Underperform rating. Nike's stock has fallen 51% over the past year. The company projected fiscal 2027 revenue to decline in the high single digits and adjusted EPS between $1.15 and $1.35. Several analysts have revised earnings estimates downward, though some suggest the stock may be undervalued.